Glasgow University science hub established to screen Covid-19 drugs A coronavirus sample is held at a laboratory in Glasgow (Andrew Milligan/PA) A £2.5 million science hub is to be established at the University of Glasgow to screen treatments for Covid-19. Crush (Covid-19 Drug-Screening and Resistance Hub) will investigate promising drugs for the virus. It will also provide drug screening for other dangerous and deadly viruses in its high containment facilities. Scientists at the hub will look to identify any possible drug and immune-resistant virus variants. Research charity LifeArc has given £2 million to the project, with additional funds provided by the Medical Research Council.